
Dermata Therapeutics, Inc.
DRMAHealthcare|Biotechnology|US
$0.76
+0.00 (+0.28%)
DCF Value
$7.66
Tangible Book / Share
$0.87
Cash / Share
$1.10
Next Earnings Report
Nov 18, 2026
EPS est. -$0.55 · Revenue est. $25.0K
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Oct 21, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Oct 15, 2026 · Accesswire
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Aug 25, 2026 · Accesswire
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
Aug 21, 2026 · Accesswire
SEC Filings (94)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 2, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 29, 2026 | 8-K | Material event | DocumentIndex |
| Oct 21, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 20, 2026 | EFFECT | DocumentIndex | |
| Oct 9, 2026 | S-3 | Shelf registration | DocumentIndex |
| Aug 17, 2026 | 25-NSE | DocumentIndex | |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Aug 5, 2026 | 8-K | Material event | DocumentIndex |
| Jun 4, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 1, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 29, 2026 | EFFECT | DocumentIndex | |
| May 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 22, 2026 | S-3/A | Shelf registration | DocumentIndex |
| May 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| Apr 22, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 17, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 17, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 17, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 7, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 25, 2026 | 8-K | Material event | DocumentIndex |
| Feb 23, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Feb 18, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 9, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 3, 2026 | 8-K | Material event | DocumentIndex |
| Feb 2, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jan 29, 2026 | EFFECT | DocumentIndex | |
| Jan 29, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 27, 2026 | 8-K | Material event | DocumentIndex |
| Jan 27, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jan 22, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 8, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jan 7, 2026 | D | DocumentIndex |